Patient Capital
Our archive holds 4 letters from Patient Capital, behind 11 investment theses. Every quote below is copied verbatim from the letter it came from.
Patient Capital’s own letters pageTheses · 11
- March 2026
Adobe Inc. is a leading creative software company with high free cash flow yield, strategic responses to competition, ongoing growth, and buybacks supporting attractive upside.
Read the full thesis - December 2025
Coinbase is evolving into a broader financial exchange with expanding products that diversify revenues and enhance long-term earnings power.
Read the full thesis - December 2025
Fiserv is a leading payments platform with embedded client relationships resetting under a new CEO, with a path back to double-digit EPS growth by 2027.
Read the full thesis - December 2025
Precigen is advancing first-in-class immunotherapies under experienced leadership, with an underappreciated pipeline and multiple potential blockbuster assets.
Read the full thesis - December 2025
Biogen benefits from late-stage pipeline and Alzheimer’s tailwinds, improved cost structure, and long-dated optionality supporting attractive risk/reward.
Read the full thesis - December 2025
Chime Financial is a fintech serving underserved consumers with strong engagement, expanding cross-sell, controlled credit risk, and a near-term path to GAAP profitability.
Read the full thesis - March 2025
Carvana is the world's largest online-only used car retailer, addressing market inefficiencies with no-negotiation pricing and rapid delivery, and poised for continued growth in a $1T market.
Read the full thesis - March 2025
JD.com Inc. is well-positioned to benefit from increased demand and improving margins in the Chinese e-commerce market, supported by a government trade-in policy and disciplined spending, while returning cash to shareholders through dividends and buybacks.
Read the full thesis - March 2025
New Fortress Energy (NFE) is a strategically positioned LNG infrastructure company poised for growth as markets shift to LNG, with potential for significant stock appreciation if management executes effectively.
Read the full thesis - December 2024
CVS Health Corp. is undergoing a turnaround with management upgrades and a clear pathway to improving margins, leveraging its diverse healthcare assets while offering an attractive 5.8% dividend yield.
Read the full thesis - December 2024
IAC Inc. is poised for value creation through strategic asset spin-offs and an attractive valuation that highlights untapped potential in its private holdings.
Read the full thesis
Letter archive · 4
Funds · 2
- Patient Capital Management3
- Patient Capital1
Get Patient Capital’s next letter the day it lands
We track Patient Capital alongside hundreds of other managers, read every letter, and pull out what they bought and sold. Warren AI reads the whole archive for you.
View plans→